Global Artemisinine Sales Market Report 2021

1 Artemisinine Market Overview

• 1.1 Artemisinine Product Scope
• 1.2 Artemisinine Segment by Type
  • 1.2.1 Global Artemisinine Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Extraction from Artemisia annua
  • 1.2.3 Semisynthetic Artemisinine
• 1.3 Artemisinine Segment by Application
  • 1.3.1 Global Artemisinine Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Injections
  • 1.3.3 Tablets
  • 1.3.4 Others
• 1.4 Artemisinine Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Artemisinine Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Artemisinine Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Artemisinine Price Trends (2016-2027)

2 Artemisinine Estimates and Forecasts by Region

• 2.1 Global Artemisinine Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Artemisinine Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Artemisinine Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Artemisinine Revenue Market Share by Region (2016-2021)
• 2.3 Global Artemisinine Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Artemisinine Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Artemisinine Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Artemisinine Estimates and Projections (2016-2027)
  • 2.4.2 Europe Artemisinine Estimates and Projections (2016-2027)
  • 2.4.3 China Artemisinine Estimates and Projections (2016-2027)
  • 2.4.4 Japan Artemisinine Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Artemisinine Estimates and Projections (2016-2027)
  • 2.4.6 India Artemisinine Estimates and Projections (2016-2027)

3 Global Artemisinine Competition Landscape by Players

• 3.1 Global Top Artemisinine Players by Sales (2016-2021)
• 3.2 Global Top Artemisinine Players by Revenue (2016-2021)
• 3.3 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artemisinine as of 2020)
• 3.4 Global Artemisinine Average Price by Company (2016-2021)
• 3.5 Manufacturers Artemisinine Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Artemisinine Market Size by Type

• 4.1 Global Artemisinine Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Artemisinine Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Artemisinine Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Artemisinine Price by Type (2016-2021)
• 4.2 Global Artemisinine Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Artemisinine Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Artemisinine Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Artemisinine Price Forecast by Type (2022-2027)

5 Global Artemisinine Market Size by Application

• 5.1 Global Artemisinine Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Artemisinine Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Artemisinine Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Artemisinine Price by Application (2016-2021)
• 5.2 Global Artemisinine Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Artemisinine Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Artemisinine Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Artemisinine Price Forecast by Application (2022-2027)

6 North America Artemisinine Market Facts & Figures

• 6.1 North America Artemisinine Sales by Company
  • 6.1.1 North America Artemisinine Sales by Company (2016-2021)
  • 6.1.2 North America Artemisinine Revenue by Company (2016-2021)
• 6.2 North America Artemisinine Sales Breakdown by Type
  • 6.2.1 North America Artemisinine Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Artemisinine Sales Breakdown by Type (2022-2027)
• 6.3 North America Artemisinine Sales Breakdown by Application
  • 6.3.1 North America Artemisinine Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Artemisinine Sales Breakdown by Application (2022-2027)

7 Europe Artemisinine Market Facts & Figures

• 7.1 Europe Artemisinine Sales by Company
  • 7.1.1 Europe Artemisinine Sales by Company (2016-2021)
  • 7.1.2 Europe Artemisinine Revenue by Company (2016-2021)
• 7.2 Europe Artemisinine Sales Breakdown by Type
  • 7.2.1 Europe Artemisinine Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Artemisinine Sales Breakdown by Type (2022-2027)
• 7.3 Europe Artemisinine Sales Breakdown by Application
  • 7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China Artemisinine Market Facts & Figures

• 8.1 China Artemisinine Sales by Company
  • 8.1.1 China Artemisinine Sales by Company (2016-2021)
  • 8.1.2 China Artemisinine Revenue by Company (2016-2021)
• 8.2 China Artemisinine Sales Breakdown by Type
  • 8.2.1 China Artemisinine Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Artemisinine Sales Breakdown by Type (2022-2027)
• 8.3 China Artemisinine Sales Breakdown by Application
  • 8.3.1 China 243 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 243 Sales Breakdown by Application (2022-2027)

9 Japan Artemisinine Market Facts & Figures

• 9.1 Japan Artemisinine Sales by Company
  • 9.1.1 Japan Artemisinine Sales by Company (2016-2021)
  • 9.1.2 Japan Artemisinine Revenue by Company (2016-2021)
• 9.2 Japan Artemisinine Sales Breakdown by Type
  • 9.2.1 Japan Artemisinine Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Artemisinine Sales Breakdown by Type (2022-2027)
• 9.3 Japan Artemisinine Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Artemisinine Market Facts & Figures

• 10.1 Southeast Asia Artemisinine Sales by Company
  • 10.1.1 Southeast Asia Artemisinine Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Artemisinine Revenue by Company (2016-2021)
• 10.2 Southeast Asia Artemisinine Sales Breakdown by Type
  • 10.2.1 Southeast Asia Artemisinine Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Artemisinine Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Artemisinine Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Artemisinine Market Facts & Figures

• 11.1 India Artemisinine Sales by Company
  • 11.1.1 India Artemisinine Sales by Company (2016-2021)
  • 11.1.2 India Artemisinine Revenue by Company (2016-2021)
• 11.2 India Artemisinine Sales Breakdown by Type
  • 11.2.1 India Artemisinine Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Artemisinine Sales Breakdown by Type (2022-2027)
• 11.3 India Artemisinine Sales Breakdown by Application
  • 11.3.1 India Artemisinine Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Artemisinine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Artemisinine Business

• 12.1 Guilin Pharmaceutical
  • 12.1.1 Guilin Pharmaceutical Corporation Information
  • 12.1.2 Guilin Pharmaceutical Business Overview
  • 12.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Guilin Pharmaceutical Artemisinine Products Offered
  • 12.1.5 Guilin Pharmaceutical Recent Development
• 12.2 CAT KHANH
  • 12.2.1 CAT KHANH Corporation Information
  • 12.2.2 CAT KHANH Business Overview
  • 12.2.3 CAT KHANH Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 CAT KHANH Artemisinine Products Offered
  • 12.2.5 CAT KHANH Recent Development
• 12.3 Novanat Bioresource
  • 12.3.1 Novanat Bioresource Corporation Information
  • 12.3.2 Novanat Bioresource Business Overview
  • 12.3.3 Novanat Bioresource Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Novanat Bioresource Artemisinine Products Offered
  • 12.3.5 Novanat Bioresource Recent Development
• 12.4 BEEPZ
  • 12.4.1 BEEPZ Corporation Information
  • 12.4.2 BEEPZ Business Overview
  • 12.4.3 BEEPZ Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 BEEPZ Artemisinine Products Offered
  • 12.4.5 BEEPZ Recent Development
• 12.5 KPC Pharmaceuticals
  • 12.5.1 KPC Pharmaceuticals Corporation Information
  • 12.5.2 KPC Pharmaceuticals Business Overview
  • 12.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 KPC Pharmaceuticals Artemisinine Products Offered
  • 12.5.5 KPC Pharmaceuticals Recent Development
• 12.6 BIONEXX
  • 12.6.1 BIONEXX Corporation Information
  • 12.6.2 BIONEXX Business Overview
  • 12.6.3 BIONEXX Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 BIONEXX Artemisinine Products Offered
  • 12.6.5 BIONEXX Recent Development
• 12.7 Guangxi xiancaotang
  • 12.7.1 Guangxi xiancaotang Corporation Information
  • 12.7.2 Guangxi xiancaotang Business Overview
  • 12.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Guangxi xiancaotang Artemisinine Products Offered
  • 12.7.5 Guangxi xiancaotang Recent Development
• 12.8 Sanofi
  • 12.8.1 Sanofi Corporation Information
  • 12.8.2 Sanofi Business Overview
  • 12.8.3 Sanofi Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Sanofi Artemisinine Products Offered
  • 12.8.5 Sanofi Recent Development
• 12.9 Natural Bio-engineering
  • 12.9.1 Natural Bio-engineering Corporation Information
  • 12.9.2 Natural Bio-engineering Business Overview
  • 12.9.3 Natural Bio-engineering Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Natural Bio-engineering Artemisinine Products Offered
  • 12.9.5 Natural Bio-engineering Recent Development
• 12.10 Kerui nanhai
  • 12.10.1 Kerui nanhai Corporation Information
  • 12.10.2 Kerui nanhai Business Overview
  • 12.10.3 Kerui nanhai Artemisinine Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Kerui nanhai Artemisinine Products Offered
  • 12.10.5 Kerui nanhai Recent Development

13 Artemisinine Manufacturing Cost Analysis

• 13.1 Artemisinine Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Artemisinine
• 13.4 Artemisinine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Artemisinine Distributors List
• 14.3 Artemisinine Customers

15 Market Dynamics

• 15.1 Artemisinine Market Trends
• 15.2 Artemisinine Drivers
• 15.3 Artemisinine Market Challenges
• 15.4 Artemisinine Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List